Advanced Search
Contact | Corporate | Help

Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive Esophagitis

Sponsors:
  • Takeda Pharmaceutical Company Limited
Phases:
  • Phase III
IndicationsAcronym:
  • Erosive Esophagitis
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: TAK-438
  • Drug: Placebo
  • Drug: Lansoprazole
  • Drug: Placebo
Enrollment:
400

Additional information about NCT01452698.


SourceSolution © 2008-2012